Symbol="ICPT"
AssetType="Common Stock"
Name="Intercept Pharmaceuticals Inc"
Description="Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company is headquartered in New York, New York."
CIK="1270073"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="18 DESBROSSES STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="456078000"
EBITDA="-66520000"
PERatio="None"
PEGRatio="-0.69"
BookValue="1.617"
DividendPerShare="0"
DividendYield="0"
EPS="-4.21"
RevenuePerShareTTM="7.7"
ProfitMargin="0.681"
OperatingMarginTTM="-0.218"
ReturnOnAssetsTTM="-0.085"
ReturnOnEquityTTM="0"
RevenueTTM="306483000"
GrossProfitTTM="284726000"
DilutedEPSTTM="-4.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.167"
AnalystTargetPrice="14.67"
TrailingPE="-"
ForwardPE="7.99"
PriceToSalesRatioTTM="1.6"
PriceToBookRatio="44.19"
EVToRevenue="1.185"
EVToEBITDA="-3.593"
Beta="1.254"
num_52WeekHigh="21.86"
num_52WeekLow="8.82"
num_50DayMovingAverage="10.85"
num_200DayMovingAverage="14.41"
SharesOutstanding="41687100"
DividendDate="None"
ExDividendDate="None"
symbol="ICPT"
open="10.40"
high="10.82"
low="10.28"
price="10.80"
volume="621815.00"
latest_trading_day="2023-08-25"
previous_close="10.36"
change="0.44"
change_percent="4.2471%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="95"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="5"
Volume_recent_avg="1151998"
Change_recent_avg="-0.01"
Delta_recent_avg="0.75"
Variance_recent_avg="0.37"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="5"
Aroon_momentum_negative="95"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="502"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
